Amycretin, developed by Novo Nordisk, employs a dual agonist approach, combining GLP-1 and amylin receptor activation in a single molecule
For patients on GLP-1 protocols who want to understand how peptide therapy can support their weight loss results, our weight loss treatment plan at Perfect B in Doral covers the full clinical approach including adjunctive peptide protocols
Missing one day is unlikely to significantly affect your results
Similarly, activation of mitochondrial CB 1 Rs with THC resulted in reduced glycolytic activity and lactate production in primary cultured astrocytes (01-days-old), which was hypothesized to contribute to the subsequent impaired neuronal function and altered behavior (e.g., social interaction deficit) in young adult (812-weeks-old) mice (Jimenez-Blasco et al., 2020)
Stay tuned for Part 3 next week, where well explore specific nutrition-based strategies to support weight loss while on GLP-1 therapy